Flock Safety Receives Frost & Sullivan’s 2025 North American New Product Innovation Recognition for Excellence in Mobile Security
Recognized for redefining mobile security through innovative, customer-centric solutions that enhance situational…
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract…
Iconic Asian Hall of Fame Inductees Highlight The American Dream
Role models convene from across the country, around the world LOS ANGELES,…
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
November 12, 2025 18:03 ET | Source: Aurora Spine Corporation Company to…
NORTH AMERICAN MANUFACTURERS CUT ORDERS AS GLOBAL SUPPLY CHAINS REMAIN UNDERUTILIZED IN OCTOBER: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
Ample global spare capacity lowers risk of goods price inflation beyond tariffs…
Frost & Sullivan: OptiSigns Receives the 2025 North American SMB Digital Signage Product Leadership Recognition for Excellence in Digital Transformation and Customer Engagement
OptiSigns recognized for redefining SMB digital signage through automation, flexibility, and enterprise-class…
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and…
Spectrum Business Receives Frost & Sullivan’s 2025 North American Competitive Strategy Leadership Recognition for Excellence in Dedicated Internet Access
Spectrum Business Leverages Digital Innovation and Customer-Centric Execution to Drive Strategic Excellence…
George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025
London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage…
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
November 09, 2025 09:00 ET | Source: Medera Inc. BOSTON, Nov. 09,…
